P.7.d.013 Long-term safety and efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder

Attention Deficit ◽

Safety And Efficacy ◽

Long-Term Safety and Efficacy of Guanfacine Extended Release in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2008.0080 ◽

2009 ◽

Vol 19 (3) ◽

pp. 215-226 ◽

Cited By ~ 96

Author(s):

Floyd R. Sallee ◽

Andrew Lyne ◽

Timothy Wigal ◽

James J. McGough

Keyword(s):

Attention Deficit ◽

Extended Release ◽

Safety And Efficacy ◽

Long‐term study of lisdexamfetamine dimesylate in Japanese children and adolescents with attention‐deficit/hyperactivity disorder

Neuropsychopharmacology Reports ◽

10.1002/npr2.12091 ◽

2019 ◽

Vol 40 (1) ◽

pp. 52-62 ◽

Cited By ~ 3

Author(s):

Hironobu Ichikawa ◽

Tasuku Miyajima ◽

Yushiro Yamashita ◽

Masakazu Fujiwara ◽

Akimasa Fukushi ◽

...

Keyword(s):

Attention Deficit ◽

Japanese Children ◽

Term Study ◽

Hyperactivity Disorder ◽

Long Term Study

P.1.i.038 Long-term safety and efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder

European Neuropsychopharmacology ◽

10.1016/s0924-977x(09)70541-3 ◽

2009 ◽

Vol 19 ◽

pp. S356

Author(s):

R. Lasser ◽

R. Weisler ◽

J. Young ◽

G. Mattingly ◽

J. Gao ◽

...

Keyword(s):

Attention Deficit ◽

Safety And Efficacy ◽

Lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder: pharmacokinetics, efficacy and safety in children and adolescents

Archives of Clinical Psychiatry (São Paulo) ◽

10.1590/0101-60830000000007 ◽

2014 ◽

Vol 41 (2) ◽

pp. 34-39 ◽

Cited By ~ 2

Author(s):

Paulo Mattos

Keyword(s):

Attention Deficit ◽

Efficacy And Safety ◽

Cognitive Function of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate

CNS Drugs ◽

10.1007/s40263-017-0487-z ◽

2018 ◽

Vol 32 (1) ◽

pp. 85-95 ◽

Cited By ~ 7

Author(s):

David R. Coghill ◽

Tobias Banaschewski ◽

Caleb Bliss ◽

Brigitte Robertson ◽

Alessandro Zuddas

Keyword(s):

Cognitive Function ◽

Attention Deficit ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

958 – Efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder: effect of age, sex and baseline disease severity

European Psychiatry ◽

10.1016/s0924-9338(13)76104-2 ◽

2013 ◽

Vol 28 ◽

pp. 1 ◽

Cited By ~ 1

Author(s):

M. Lecendreux ◽

T. Banaschewski ◽

C. Soutullo ◽

M. Johnson ◽

A. Zuddas ◽

...

Keyword(s):

Disease Severity ◽

Attention Deficit ◽

Hyperactivity Disorder ◽

Disorder Effect ◽

Effect Of Age ◽

Baseline Disease Severity

Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

CNS Drugs ◽

10.1007/s40263-018-0514-8 ◽

2018 ◽

Vol 32 (5) ◽

pp. 455-467 ◽

Cited By ~ 6

Author(s):

Tobias Banaschewski ◽

Mats Johnson ◽

Peter Nagy ◽

Isabel Hernández Otero ◽

César A. Soutullo ◽

...

Keyword(s):

Attention Deficit ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

P.7.a.009 Long-term effectiveness and safety of lisdexamfetamine dimesylate in children aged 6−12 with attention-deficit/hyperactivity disorder

European Neuropsychopharmacology ◽

10.1016/s0924-977x(08)70851-4 ◽

2008 ◽

Vol 18 ◽

pp. S559

Author(s):

J. McGough ◽

A. Childress ◽

S. Krishnan ◽

R. Findling

Keyword(s):

Attention Deficit ◽

Efficacy of lisdexamfetamine dimesylate throughout the day in children and adolescents with attention-deficit/hyperactivity disorder: results from a randomized, controlled trial

European Child & Adolescent Psychiatry ◽

10.1007/s00787-013-0421-y ◽

2013 ◽

Vol 23 (2) ◽

pp. 61-68 ◽

Cited By ~ 20

Author(s):

David R. Coghill ◽

Tobias Banaschewski ◽

Michel Lecendreux ◽

Alessandro Zuddas ◽

Ralf W. Dittmann ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Attention Deficit ◽

Controlled Trial ◽

Hyperactivity Disorder ◽

Randomized Controlled

A Long-Term Open-Label Safety and Effectiveness Trial of Lisdexamfetamine Dimesylate in Adolescents With Attention-Deficit/Hyperactivity Disorder

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2011.0088 ◽

2013 ◽

Vol 23 (1) ◽

pp. 11-21 ◽

Cited By ~ 22

Author(s):

Robert L. Findling ◽

Andrew J. Cutler ◽

Keith Saylor ◽

Maria Gasior ◽

Mohamed Hamdani ◽

...

Keyword(s):

Attention Deficit ◽

Effectiveness Trial ◽

Open Label ◽